Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Marius Trøseid, José Ramón Arribas, Lambert Assoumou, Aleksander Rygh Holten et autres
no, es, fr, it, ie, be, at, pt, lu, de, sk, hu, gr, cz, ch, tr (code pays fourni par la source)